论文部分内容阅读
目的:研究产前免疫血液学检查在预测新生儿溶血病中的应用价值。方法:应用经典抗人球法进行相应的IgG抗体效价检查,对我院2012年4月至2015年2月份申请做产前免疫血液学检测的280例孕夫妇双方进行抽血,男方检测:ABO正反定血型,RHD血型;女方检测:ABO正反定血型,RhD血型,相应的IgG抗A﹙B﹚抗体效价,抗体筛选试验。跟踪致新生儿出生,做新生儿溶血三项试验。结果:标本280例,阳性患者53例,占18.93%。结论:产前免疫血液学检查在预测新生儿溶血病中的应用疗效确切,提示临床采取相应的预防、治疗措施,减少新生儿溶血病的发生。对优生优育,对提高人口素质具有重要意义。
Objective: To study the value of prenatal immune hematology in predicting hemolytic disease of newborn. Methods: The classical anti-human-ball method was used to test the titer of IgG antibody. Blood samples were taken from 280 pregnant couples who applied for prenatal immune hematology test from April 2012 to February 2015 in our hospital. ABO positive and negative blood group, RHD blood group; woman test: ABO positive and negative blood group, RhD blood group, the corresponding IgG anti-A (B) antibody titer, antibody screening test. Tracking birth to newborns, neonatal hemolysis three trials. Results: There were 280 specimens and 53 positive specimens (18.93%). Conclusion: The application of prenatal immune hematology in predicting neonatal hemolytic disease is effective, which suggests that the preventive and therapeutic measures should be taken clinically to reduce the incidence of hemolytic disease in newborn. Prenatal and postnatal care, to improve the quality of the population is of great significance.